Lactoferrin

The first function attributed to lactoferrin (Lf), an iron binding protein belonging to the non-immune natural defences, was antimicrobial activity that depended on its capacity to sequester iron. Iron-independent microbicidal activities, requiring direct interaction between this cationic protein and microbial surface components, were later demonstrated. Many other anti-microbial and anti-viral functions have since been ascribed to Lf. In mucosal secretions, iron and Lf modulate the motility and aggregation of pathogenic bacteria. Lf inhibits bacterial adhesion on abiotic surfaces through ionic binding to biomaterials, or specific binding to bacterial structures or both. Lf inhibition of bacterial adhesion to host cells requires Lf binding to bacteria and/or host cells. Lf hinders microbial internalization by binding to both glycosaminoglycans and bacterial proteins which can be degraded by Lf-mediated proteolysis. Moreover, Lf internalisation and localisation to the host cell nuclei could modulate bacterial entry into cells through gene regulation. Finally, the capability of Lf to exert antiviral activity, through its binding to host cells and/or viral particles, strengthens the idea that it is an important brick in the mucosal wall, effective against both microbial and viral attacks.

[1]  E. Baker,et al.  Human milk lactoferrin inactivates two putative colonization factors expressed by Haemophilus influenzae. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[2]  N. Kato,et al.  Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. , 1998, Biochemical and biophysical research communications.

[3]  M. Andrés,et al.  Modulation of In Vitro Fungicidal Activity of Human Lactoferrin against Candida albicans by Extracellular Cation Concentration and Target Cell Metabolic Activity , 2004, Antimicrobial Agents and Chemotherapy.

[4]  P. Valenti,et al.  Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. , 1996, Antiviral research.

[5]  T. Williams,et al.  The effect of protein-coated contact lenses on the adhesion and viability of gram negative bacteria , 2003, Current eye research.

[6]  E. Pauwels,et al.  Human Lactoferrin and Peptides Derived from Its N Terminus Are Highly Effective against Infections with Antibiotic-Resistant Bacteria , 2001, Infection and Immunity.

[7]  Alessandro Tossi,et al.  Amphipathic, α‐helical antimicrobial peptides , 2000 .

[8]  D. Meijer,et al.  Synergistic Fungistatic Effects of Lactoferrin in Combination with Antifungal Drugs against ClinicalCandida Isolates , 1999, Antimicrobial Agents and Chemotherapy.

[9]  E. De Clercq,et al.  Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. , 1995, The Journal of infectious diseases.

[10]  J. Tommassen,et al.  Molecular characterization of LbpB, the second lactoferrin‐binding protein of Neisseria meningitidis , 1998, Molecular microbiology.

[11]  B. Lönnerdal,et al.  Cellular internalization of lactoferrin in intestinal epithelial cells , 2004, Biometals.

[12]  Eric P. Skaar,et al.  Iron-Source Preference of Staphylococcus aureus Infections , 2004, Science.

[13]  L. G. Giugliano,et al.  In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins , 2004, BMC Microbiology.

[14]  R. M. Bennett,et al.  Lactoferrin turnover in man. , 1979, Clinical science.

[15]  M. Dathe,et al.  Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization. , 2004, The journal of peptide research : official journal of the American Peptide Society.

[16]  P. Visca,et al.  Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. , 1988, Microbiologica.

[17]  J. Mcghee,et al.  A bactericidal effect for human lactoferrin. , 1977, Science.

[18]  S. Tanaka,et al.  Inhibition with lactoferrin of in vitro infection with human herpes virus. , 1994, Japanese journal of medical science & biology.

[19]  S. Abe,et al.  Cooperative Anti‐Candida Effects of Lactoferrin or Its Peptides in Combination with Azole Antifungal Agents , 1996, Microbiology and immunology.

[20]  E. De Clercq,et al.  Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. , 1996, AIDS research and human retroviruses.

[21]  N. Kato,et al.  Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.

[22]  H. Milch,et al.  In vitro and in vivo (LD50) effects of human lactoferrin on bacteria. , 1990, Acta microbiologica Hungarica.

[23]  A. Tamanini,et al.  Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. , 2000, Virology.

[24]  P. Ward,et al.  Cooperative Interactions between the Amino- and Carboxyl-terminal Lobes Contribute to the Unique Iron-binding Stability of Lactoferrin* , 1996, The Journal of Biological Chemistry.

[25]  M. Tomita,et al.  A review: The active peptide of lactoferrin , 1994, Acta paediatrica Japonica : Overseas edition.

[26]  T. Fujihara,et al.  Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea , 2005, Archives of Virology.

[27]  C. Ratledge,et al.  Iron metabolism in pathogenic bacteria. , 2000, Annual review of microbiology.

[28]  G. Grondin,et al.  Lactoferrin against Staphylococcus aureus Mastitis. Lactoferrin alone or in combination with penicillin G on bovine polymorphonuclear function and mammary epithelial cells colonisation by Staphylococcus aureus. , 2003, Veterinary immunology and immunopathology.

[29]  T. Ochoa,et al.  Lactoferrin blocks the initial host cell attachment mechanism of Enteropathogenic E. coli (EPEC). , 2004, Advances in experimental medicine and biology.

[30]  C. Sciortino,et al.  Role of iron in microbe-host interactions. , 1983, Reviews of infectious diseases.

[31]  A. O'Brien-Ladner,et al.  Increased iron and ferritin content of sputum from patients with cystic fibrosis or chronic bronchitis. , 1998, Chest.

[32]  P. Visca,et al.  INTERACTION BETWEEN LACTOFERRIN AND OVOTRANSFERRIN AND CANDIDA CELLS , 1986 .

[33]  L. G. Giugliano,et al.  Lactoferrin and free secretory component of human milk inhibit the adhesion of enteropathogenic Escherichia coli to HeLa cells , 2001, BMC Microbiology.

[34]  L. Samaranayake,et al.  In vitro susceptibility of Candida species to lactoferrin. , 1999, Medical mycology.

[35]  H. Broxmeyer,et al.  Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. , 1987, Cancer research.

[36]  R. Pakkanen,et al.  Growth factors and antimicrobial factors of bovine colostrum , 1997 .

[37]  A. Schryvers,et al.  Lactoferrin receptors in Gram-negative bacteria: Insights into the iron acquisition process , 2004, Biometals.

[38]  P. Ascenzi,et al.  Proteolytic activity of bovine lactoferrin , 2004, Biometals.

[39]  K. Yamauchi,et al.  Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. , 1991, Journal of dairy science.

[40]  F. Superti,et al.  Effect of bovine lactoferricin on enteropathogenic Yersinia adhesion and invasion in HEp-2 cells. , 2004, Journal of medical microbiology.

[41]  A. Pilotto,et al.  Use of bovine lactoferrin for Helicobacter pylori eradication. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[42]  K. Yamauchi,et al.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.

[43]  B. Doebbeling,et al.  Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis , 1993, Infection and immunity.

[44]  F. Grundy,et al.  Growth of Haemophilus influenzae in human milk: synthesis, distribution, and activity of IgA protease as determined by study of iga+ and mutant iga- cells. , 1992, The Journal of infectious diseases.

[45]  M. Eisenstein,et al.  Modulation of the hydrophobic domain of polymyxin B nonapeptide: effect on outer-membrane permeabilization and lipopolysaccharide neutralization. , 2002, Molecular pharmacology.

[46]  O. Conneely,et al.  Lactoferrin and host defense. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[47]  J. Brock The physiology of lactoferrin. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[48]  V. Salmon,et al.  Lactoferrin Inhibits the Endotoxin Interaction with CD14 by Competition with the Lipopolysaccharide-Binding Protein , 1998, Infection and Immunity.

[49]  S. Gray-Owen,et al.  Bacterial transferrin and lactoferrin receptors. , 1996, Trends in microbiology.

[50]  P. Valenti,et al.  Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2 , 1998, Biometals.

[51]  M. Ajello,et al.  Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans , 2004, Biometals.

[52]  A. Alfsen,et al.  Influence of lactoferrin on the entry process of Escherichia coli HB101(pRI203) in HeLa cells , 1993, Medical Microbiology and Immunology.

[53]  Edward N Baker,et al.  Lactoferrin and transferrin: functional variations on a common structural framework. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[54]  S. Kaneko,et al.  Hepatitis C virus envelope proteins bind lactoferrin , 1997, Journal of virology.

[55]  J. Tachezy,et al.  Tritrichomonas foetus: iron acquisition from lactoferrin and transferrin. , 1996, Experimental parasitology.

[56]  H. Matsuzawa,et al.  Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell-dependent augmentation of natural killer cell activity , 2005, Archives of Virology.

[57]  P. Visca,et al.  Growth and adsorption of Streptococcus mutans 6715-13 to hydroxyapatite in the presence of lactoferrin , 2004, Medical Microbiology and Immunology.

[58]  R. Siciliano,et al.  Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection. , 1999, Biochemical and biophysical research communications.

[59]  H. Rogers,et al.  Iron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants , 1972, Proceedings of the Royal Society of Medicine.

[60]  L. Samaranayake,et al.  Modulation of the anti-Candida activity of apo-lactoferrin by dietary sucrose and tunicamycin in vitro. , 1995, Archives of oral biology.

[61]  D. Spira,et al.  Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin. , 1987, Experimental parasitology.

[62]  H. Isoda,et al.  Inhibitory Effects of Bovine Lactoferrin on the Adherence of Enterotoxigenic Escherichia coli to Host Cells , 2000, Bioscience, biotechnology, and biochemistry.

[63]  M. Shakibaei,et al.  Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans , 1996, The Journal of experimental medicine.

[64]  T. Ochoa,et al.  Lactoferrin disruption of bacterial type III secretion systems , 2004, Biometals.

[65]  C. Guzmán,et al.  Lactoferrin Impairs Type III Secretory System Function in Enteropathogenic Escherichia coli , 2003, Infection and Immunity.

[66]  L. Samaranayake,et al.  The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei. , 1993, Archives of oral biology.

[67]  A. Pietrantoni,et al.  Bovine Lactoferrin Inhibits Adenovirus Infection by Interacting with Viral Structural Polypeptides , 2003, Antimicrobial Agents and Chemotherapy.

[68]  M. Tomita,et al.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. , 1992, The Journal of applied bacteriology.

[69]  T. Ochoa,et al.  Lactoferrin Protects Rabbits from Shigella flexneri-Induced Inflammatory Enteritis , 2002, Infection and Immunity.

[70]  D. Newburg,et al.  Protective role of human lactoferrin against invasion of Shigella flexneri M90T. , 2001 .

[71]  M. Willcox,et al.  Synergic antistaphylococcal properties of lactoferrin and lysozyme. , 1998, Journal of medical microbiology.

[72]  K. Mikawa,et al.  Properties of a heparin-binding peptide derived from bovine lactoferrin. , 1998, Journal of dairy science.

[73]  Ø. Rekdal,et al.  Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. , 1998, Scandinavian journal of infectious diseases.

[74]  B. Berkhout,et al.  The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1 , 2004, Biometals.

[75]  L. Lichtenberger,et al.  Effect of lactoferrin on Helicobacter felis induced gastritis. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[76]  M. Ammendolia,et al.  Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29 , 1997, Medical Microbiology and Immunology.

[77]  K. Yamauchi,et al.  Bovine lactoferrin and lactoferricin derived from milk: production and applications. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[78]  A. Pietrantoni,et al.  Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection. , 2002, Antiviral research.

[79]  J. S. St. Geme,et al.  Human lactoferrin proteolytic activity: analysis of the cleaved region in the IgA protease of Haemophilus influenzae. , 2000, Vaccine.

[80]  S. Kalfas,et al.  Characterization of the lactoferrin‐dependent inhibition of the adhesion of Actinobacilllus actinomycetemcomitans, Prevotella intermedia and Prevotella nigrescens to fibroblasts and to a reconstituted basement membrane , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[81]  P. Valenti,et al.  Involvement of bovine lactoferrin moieties in the inhibition of herpes simplex virus type 1 infection. , 2001, International Journal of Immunopathology and Pharmacology.

[82]  J. E. Rose,et al.  Aae, an Autotransporter Involved in Adhesion of Actinobacillus actinomycetemcomitans to Epithelial Cells , 2003, Infection and Immunity.

[83]  P. Visca,et al.  The effect of saturation with Zn2+ and other metal ions on the antibacterial activity of ovotransferrin , 2004, Medical Microbiology and Immunology.

[84]  E. Greenberg,et al.  A component of innate immunity prevents bacterial biofilm development , 2002, Nature.

[85]  R. Siciliano,et al.  Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. , 2001, Biochimica et biophysica acta.

[86]  S. Abe,et al.  Potential usefulness of bovine lactoferrin for adjunctive immunotherapy for mucosal Candida infections , 2004, Biometals.

[87]  L. G. Giugliano,et al.  Human milk fractions inhibit the adherence of diffusely adherent Escherichia coli (DAEC) and enteroaggregative E. coli (EAEC) to HeLa cells. , 2000, FEMS microbiology letters.

[88]  B. Lönnerdal,et al.  Lactoferrin: molecular structure and biological function. , 1995, Annual review of nutrition.

[89]  P. Masson,et al.  Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. , 1966, Thorax.

[90]  K. Yamauchi,et al.  Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. , 2001, The Journal of veterinary medical science.

[91]  F. Del Chierico,et al.  Effect on bovine lactoferrin on the activation of the enteroinvasive bacterial type III secretion system , 2004, Biometals.

[92]  B. Appelmelk,et al.  Lactoferrin is a lipid A-binding protein , 1994, Infection and immunity.

[93]  E. Weinberg Human lactoferrin: a novel therapeutic with broad spectrum potential , 2001, The Journal of pharmacy and pharmacology.

[94]  Y. Makino,et al.  High-performance liquid chromatographic separation of human apolactoferrin and monoferric and diferric lactoferrins. , 1991, Journal of chromatography.

[95]  R. Arnold,et al.  Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms , 1980, Infection and immunity.

[96]  E. Antonini,et al.  Antibacterial activity of matrix-bound ovotransferrin , 1982, Antimicrobial Agents and Chemotherapy.

[97]  V. Nussenzweig,et al.  Remnant lipoproteins inhibit malaria sporozoite invasion of hepatocytes , 1996, The Journal of experimental medicine.

[98]  N. McElvaney,et al.  Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis. , 2004, The Journal of infectious diseases.

[99]  G. Weinberg Iron chelators as therapeutic agents against Pneumocystis carinii , 1994, Antimicrobial Agents and Chemotherapy.

[100]  D. Monroe,et al.  Characterization of the glycosaminoglycan-binding region of lactoferrin. , 1995, Archives of biochemistry and biophysics.

[101]  V. Braun,et al.  Active transport of iron and siderophore antibiotics. , 2002, Current opinion in microbiology.

[102]  H. Nikaido,et al.  Molecular basis of bacterial outer membrane permeability. , 1985, Microbiological reviews.

[103]  S. Rennard,et al.  Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis. , 1990, The Journal of laboratory and clinical medicine.

[104]  P. Valenti,et al.  Anti-invasive activity of bovine lactoferrin towards group A streptococci. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[105]  E. Baker,et al.  Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine‐rich sites , 2003, Molecular microbiology.

[106]  F. Barchiesi,et al.  Inhibition of growth of Pneumocystis carinii by lactoferrins alone and in combination with pyrimethamine, clarithromycin and minocycline. , 2000, The Journal of antimicrobial chemotherapy.

[107]  S. Kalfas,et al.  Degradation of lactoferrin by periodontitis-associated bacteria. , 1996, FEMS microbiology letters.

[108]  M. Harmsen,et al.  Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. , 2004, Antiviral research.

[109]  B. Roe,et al.  Identification and Molecular Analysis oflbpBA, Which Encodes the Two-Component Meningococcal Lactoferrin Receptor , 1998, Infection and Immunity.

[110]  F. Belardelli,et al.  Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. , 1998, The international journal of biochemistry & cell biology.

[111]  M. Andrés,et al.  Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. , 1998, FEMS immunology and medical microbiology.

[112]  N. E. Hansen,et al.  Turnover of human lactoferrin in the rabbit. , 2009, Scandinavian journal of haematology.

[113]  H. Baker,et al.  Lactoferrin and Iron: structural and dynamic aspects of binding and release , 2004, Biometals.

[114]  Michael P. Sherman,et al.  Neonatal small bowel epithelia: enhancing anti-bacterial defense with lactoferrin and Lactobacillus GG , 2004, Biometals.

[115]  K. Hayashi,et al.  Inhibitory effect of lactoferrin on the adhesion of Prevotella nigrescens ATCC 25261 to hydroxyapatite. , 2000, Journal of oral science.

[116]  H. Kuwata,et al.  Protection against infections by oral lactoferrin: Evaluation in animal models , 2004, Biometals.

[117]  R. Arnold,et al.  Bactericidal Activity of Human Lactoferrin: Differentiation from the Stasis of Iron Deprivation , 1982, Infection and immunity.

[118]  K. Brandenburg,et al.  Biophysical Characterization of Lipopolysaccharide and Lipid A Inactivation by Lactoferrin , 2001, Biological chemistry.

[119]  H. Nagasawa,et al.  The detection of bovine lactoferrin binding protein on Trypanosoma brucei. , 2004, The Journal of veterinary medical science.

[120]  E. Weinberg Suppression of bacterial biofilm formation by iron limitation. , 2004, Medical hypotheses.

[121]  B. Dunn,et al.  Lactoferrin and transferrin damage of the gram-negative outer membrane is modulated by Ca2+ and Mg2+. , 1990, Journal of general microbiology.

[122]  K. Shimazaki,et al.  Susceptibilities against bovine lactoferrin with microorganisms isolated from mastitic milk. , 2004, The Journal of veterinary medical science.

[123]  M. Lima,et al.  Lactoferrin effects of phagocytic cell function. II. The presence of iron is required for the lactoferrin molecule to stimulate intracellular killing by macrophages but not to enhance the uptake of particles and microorganisms. , 1987, Journal of immunology.

[124]  F. Superti,et al.  Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. , 2004, Virology.

[125]  A. Pietrantoni,et al.  Heparin‐interacting sites of bovine lactoferrin are involved in anti‐adenovirus activity , 2003, Journal of medical virology.

[126]  T. Ochoa,et al.  Human lactoferrin impairs virulence of Shigella flexneri. , 2003, The Journal of infectious diseases.

[127]  S. Andrews,et al.  Bacterial iron homeostasis. , 2003, FEMS microbiology reviews.

[128]  A. Forsgren,et al.  Correlation between human lactoferrin binding and colicin susceptibility in Escherichia coli , 1991, Antimicrobial Agents and Chemotherapy.